{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:58:54Z","timestamp":1763564334554,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2301004"],"award-info":[{"award-number":["2021YFC2301004"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National key inspection specialty construction projects"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s42770-023-01192-y","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T03:02:22Z","timestamp":1701918142000},"page":"323-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Resistance phenotype and genetic features of a heterogeneous vancomycin intermediate\u2013resistant Staphylococcus aureus strain from an immunocompromised patient"],"prefix":"10.1007","volume":"55","author":[{"given":"Xin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1709-6083","authenticated-orcid":false,"given":"Jianrong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"1192_CR1","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","volume":"350","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S et al (1997) Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670\u20131673. https:\/\/doi.org\/10.1016\/S0140-6736(97)07324-8","journal-title":"Lancet"},{"key":"1192_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/jac\/40.1.135","volume":"40","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135\u2013136. https:\/\/doi.org\/10.1093\/jac\/40.1.135","journal-title":"J Antimicrob Chemother"},{"key":"1192_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1086\/596629","volume":"199","author":"Y Maor","year":"2009","unstructured":"Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G (2009) Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 199:619\u2013624. https:\/\/doi.org\/10.1086\/596629","journal-title":"J Infect Dis"},{"key":"1192_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1086\/596629","volume":"47","author":"M Wootton","year":"2001","unstructured":"Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP (2001) A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 47:399\u2013403. https:\/\/doi.org\/10.1086\/596629","journal-title":"J Antimicrob Chemother"},{"key":"1192_CR5","doi-asserted-by":"publisher","first-page":"5843e53","DOI":"10.1128\/AAC.00425-13","volume":"57","author":"M Matsuo","year":"2013","unstructured":"Matsuo M, Cui L, Kim J, Hiramatsu K (2013) Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3. Antimicrob Agents Chemother 57:5843e53. https:\/\/doi.org\/10.1128\/AAC.00425-13","journal-title":"Antimicrob Agents Chemother"},{"key":"1192_CR6","doi-asserted-by":"publisher","first-page":"5845e51","DOI":"10.1128\/AAC.01139-12","volume":"56","author":"C Hafer","year":"2012","unstructured":"Hafer C, Lin Y, Kornblum J, Lowy FD, Uhlemann AC (2012) Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 56:5845e51. https:\/\/doi.org\/10.1128\/AAC.01139-12","journal-title":"Antimicrob Agents Chemother"},{"key":"1192_CR7","volume-title":"M100-Performance Standards for Antimicrobial Susceptibility Testing","author":"The Clinical and Laboratory Standards Institute","year":"2022","unstructured":"The Clinical and Laboratory Standards Institute (2022) M100-Performance Standards for Antimicrobial Susceptibility Testing, 32nd edn. Malvern, Pennsylvania","edition":"32"},{"key":"1192_CR8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/antibiotics12020372","volume":"12","author":"S Di Gregorio","year":"2023","unstructured":"Di Gregorio S, Haim MS, Famiglietti \u00c1MR, Di Conza J, Mollerach M (2023) Comparative genomics identifies novel genetic changes associated with oxacillin, vancomycin and daptomycin susceptibility in ST100 methicillin-resistant Staphylococcus aureus. Antibiotics (Basel) 12:372. https:\/\/doi.org\/10.3390\/antibiotics12020372","journal-title":"Antibiotics (Basel)"},{"key":"1192_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovi\u0107","year":"2007","unstructured":"Stepanovi\u0107 S, Vukovi\u0107 D, Hola V, Di Bonaventura G, Djuki\u0107 S, Cirkovi\u0107 I, Ruzicka F (2007) Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115:891\u2013899. https:\/\/doi.org\/10.1111\/j.1600-0463.2007.apm_630.x","journal-title":"APMIS"},{"key":"1192_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1046\/j.1469-0691.2003.00676.x","volume":"9","author":"S Stepanovi\u0107","year":"2003","unstructured":"Stepanovi\u0107 S, Djuki\u0107 N, Djordjevi\u0107 V, Djuki\u0107 S (2003) Influence of the incubation atmosphere on the production of biofilm by staphylococci. Clin Microbiol Infect 9:955\u2013958. https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00676.x","journal-title":"Clin Microbiol Infect"},{"key":"1192_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/mdr.2014.0190","volume":"21","author":"S Di Gregorio","year":"2015","unstructured":"Di Gregorio S, Perazzi B, Ordo\u00f1ez AM, De Gregorio S, Foccoli M, Lasala MB et al (2015) Clinical, microbiological, and genetic characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a teaching hospital. Microb Drug Resist 21:25\u201334. https:\/\/doi.org\/10.1089\/mdr.2014.0190","journal-title":"Microb Drug Resist"},{"key":"1192_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/JCM.01128-10","volume":"49","author":"SW Satola","year":"2011","unstructured":"Satola SW, Farley MM, Anderson KF, Patel JB (2011) Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol 49:177\u2013183. https:\/\/doi.org\/10.1128\/JCM.01128-10","journal-title":"J Clin Microbiol"},{"key":"1192_CR13","doi-asserted-by":"publisher","first-page":"D277","DOI":"10.1093\/nar\/gkh063","volume":"32","author":"M Kanehisa","year":"2004","unstructured":"Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32:D277\u2013D280. https:\/\/doi.org\/10.1093\/nar\/gkh063","journal-title":"Nucleic Acids Res"},{"key":"1192_CR14","doi-asserted-by":"publisher","first-page":"D354","DOI":"10.1093\/nar\/gkj102","volume":"34","author":"M Kanehisa","year":"2006","unstructured":"Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S et al (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34:D354\u2013D357. https:\/\/doi.org\/10.1093\/nar\/gkj102","journal-title":"Nucleic Acids Res"},{"key":"1192_CR15","doi-asserted-by":"publisher","first-page":"D261","DOI":"10.1093\/nar\/gku1223","volume":"43","author":"MY Galperin","year":"2015","unstructured":"Galperin MY, Makarova KS, Wolf YI, Koonin EV (2015) Expanded microbial genome coverage and improved protein family annotation in the COG database. Nucleic Acids Res 43:D261\u2013D269. https:\/\/doi.org\/10.1093\/nar\/gku1223","journal-title":"Nucleic Acids Res"},{"key":"1192_CR16","doi-asserted-by":"publisher","first-page":"D641","DOI":"10.1093\/nar\/gkr989","volume":"40","author":"L Chen","year":"2012","unstructured":"Chen L, Xiong Z, Sun L, Yang J, Jin Q (2012) VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res 40:D641\u2013D645. https:\/\/doi.org\/10.1093\/nar\/gkr989","journal-title":"Nucleic Acids Res"},{"key":"1192_CR17","doi-asserted-by":"publisher","first-page":"D443","DOI":"10.1093\/nar\/gkn656","volume":"37","author":"B Liu","year":"2009","unstructured":"Liu B, Pop M (2009) ARDB-antibiotic resistance genes database. Nucleic Acids Res 37:D443\u2013D447. https:\/\/doi.org\/10.1093\/nar\/gkn656","journal-title":"Nucleic Acids Res"},{"key":"1192_CR18","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/gb-2004-5-2-r12","volume":"5","author":"S Kurtz","year":"2004","unstructured":"Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C, Salzberg SL (2004) Versatile and open software for comparing large genomes. Genome Biol 5:R12. https:\/\/doi.org\/10.1186\/gb-2004-5-2-r12","journal-title":"Genome Biol"},{"key":"1192_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jac\/dkac363","volume":"78","author":"BE Castro","year":"2022","unstructured":"Castro BE, Rios R, Carvajal LP, Vargas ML, Cala MP, Le\u00f3n L et al (2022) Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America. J Antimicrob Chemother. 78:122\u2013132. https:\/\/doi.org\/10.1093\/jac\/dkac363","journal-title":"J Antimicrob Chemother."},{"key":"1192_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/antibiotics10050583","volume":"10","author":"R Lamichhane-Khadka","year":"2021","unstructured":"Lamichhane-Khadka R, Dulal S, Cuaron JA, Pfeltz R, Gupta SK, Wilkinson BJ, Gustafson JE (2021) Apt (adenine phosphoribosyltransferase) mutation in laboratory-selected vancomycin-intermediate Staphylococcus aureus. Antibiotics (Basel) 10:583. https:\/\/doi.org\/10.3390\/antibiotics10050583","journal-title":"Antibiotics (Basel)"},{"key":"1192_CR21","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/antibiotics12050928","volume":"12","author":"V Gostev","year":"2023","unstructured":"Gostev V, Kalinogorskaya O, Sopova J, Sulian O, Chulkova P, Velizhanina M et al (2023) Adaptive laboratory evolution of Staphylococcus aureus resistance to vancomycin and daptomycin: mutation patterns and cross-resistance. Antibiotics (Basel) 12:928. https:\/\/doi.org\/10.3390\/antibiotics12050928","journal-title":"Antibiotics (Basel)"},{"key":"1192_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/s0369-8114(02)00345-0","volume":"50","author":"E Lecaillon","year":"2002","unstructured":"Lecaillon E, Gueudet P, Wooton M, Walsh TR, Macgowan AP, Jones ME (2002) Endemic heteroresistant glycopeptide intermediate Staphylococcus aureus (hGISA) comprising unrelated clonal types and not associated with vancomycin therapy. Pathol Biol (Paris) 50:525\u2013529. https:\/\/doi.org\/10.1016\/s0369-8114(02)00345-0","journal-title":"Pathol Biol (Paris)"},{"key":"1192_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s10156-011-0330-2","volume":"18","author":"J Yamakawa","year":"2012","unstructured":"Yamakawa J, Aminaka M, Okuzumi K, Kobayashi H, Katayama Y, Kondo S et al (2012) Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study. J Infect Chemother 18:406\u2013409. https:\/\/doi.org\/10.1007\/s10156-011-0330-2","journal-title":"J Infect Chemother"},{"key":"1192_CR24","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/jac\/dkab488","volume":"77","author":"T Gaillard","year":"2022","unstructured":"Gaillard T, Dupieux-Chabert C, Butin M, Dumitrescu O, Naceur O, Bouveyron C et al (2022) Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure. J Antimicrob Chemother 77:1032\u20131035. https:\/\/doi.org\/10.1093\/jac\/dkab488","journal-title":"J Antimicrob Chemother"},{"key":"1192_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/jac\/48.5.727","volume":"48","author":"J Turner","year":"2001","unstructured":"Turner J, Howe RA, Wootton M, Bowker KE, Holt HA, Salisbury V et al (2001) The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model. J Antimicrob Chemother 48:727\u2013730. https:\/\/doi.org\/10.1093\/jac\/48.5.727","journal-title":"J Antimicrob Chemother"},{"key":"1192_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.diagmicrobio.2015.03.014","volume":"82","author":"R Khatib","year":"2015","unstructured":"Khatib R, Sharma M, Johnson LB, Riederer K, Shemes S, Szpunar S (2015) Decreasing prevalence of isolates with vancomycin heteroresistance and vancomycin minimum inhibitory concentrations \u22652 mg\/L in methicillin-resistant Staphylococcus aureus over 11 years: potential impact of vancomycin treatment guidelines. Diagn Microbiol Infect Dis 82:245\u2013248. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.03.014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1192_CR27","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.3390\/molecules27217319","volume":"27","author":"X Cheng","year":"2022","unstructured":"Cheng X, Ma J, Su J (2022) An overview of analytical methodologies for determination of vancomycin in human plasma. Molecules 27:7319. https:\/\/doi.org\/10.3390\/molecules27217319","journal-title":"Molecules"},{"key":"1192_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/IDR.S393415","volume":"16","author":"S M","year":"2023","unstructured":"M S, Mulki SS, Shenoy S, Dhanashree B, M C, Bhat G (2023) Heterogeneous vancomycin intermediate Staphylococcus aureus infections in diabetic and non-diabetic patients \u2013 a hospital-based comparative study. Infect Drug Resist 16:9\u201317. https:\/\/doi.org\/10.2147\/IDR.S393415","journal-title":"Infect Drug Resist"},{"key":"1192_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.meegid.2013.03.047","volume":"21","author":"BP Howden","year":"2014","unstructured":"Howden BP, Peleg AY, Stinear TP (2014) The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA. Infect Genet Evol 21:575\u2013582. https:\/\/doi.org\/10.1016\/j.meegid.2013.03.047","journal-title":"Infect Genet Evol"},{"key":"1192_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2147\/IDR.S392908","volume":"16","author":"J Liang","year":"2023","unstructured":"Liang J, Hu Y, Fu M, Li N, Wang F, Yu X, Ji B (2023) Resistance and molecular characteristics of methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate Staphylococcus aureus. Infect Drug Resist 16:379\u2013388. https:\/\/doi.org\/10.2147\/IDR.S392908","journal-title":"Infect Drug Resist"},{"key":"1192_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/s12879-017-2833-7","volume":"17","author":"X Yang","year":"2017","unstructured":"Yang X, Qian S, Yao K, Wang L, Liu Y, Dong F et al (2017) Multiresistant ST59-SCCmec IV-t437 clone with strong biofilm-forming capacity was identified predominantly in MRSA isolated from Chinese children. BMC Infect Dis 17:733. https:\/\/doi.org\/10.1186\/s12879-017-2833-7","journal-title":"BMC Infect Dis"},{"key":"1192_CR32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jinf.2019.10.005","volume":"79","author":"X Chen","year":"2019","unstructured":"Chen X, Sun K, Luo Q, Duan Y, Chen F (2019) Emergence and spread of pvl-positive genotypic CA-MRSA ST59 with increased adhesion capacity from wounds in hospitals. J Infect 79:612\u2013625. https:\/\/doi.org\/10.1016\/j.jinf.2019.10.005","journal-title":"J Infect"},{"key":"1192_CR33","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/CORR.0000000000001740","volume":"479","author":"R Manasherob","year":"2021","unstructured":"Manasherob R, Mooney JA, Lowenberg DW, Bollyky PL, Amanatullah DF (2021) Tolerant small-colony variants form prior to resistance within a Staphylococcus aureus biofilm based on antibiotic selective pressure. Clin Orthop Relat Res 479:1471\u20131481. https:\/\/doi.org\/10.1097\/CORR.0000000000001740","journal-title":"Clin Orthop Relat Res"},{"key":"1192_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2180-4-19","volume":"4","author":"G Fa\u00fandez","year":"2004","unstructured":"Fa\u00fandez G, Troncoso M, Navarrete P, Figueroa G (2004) Antimicrobial activity of copper surfaces against suspensions of Salmonella enterica and Campylobacter jejuni. BMC Microbiol 4:19. https:\/\/doi.org\/10.1186\/1471-2180-4-19","journal-title":"BMC Microbiol"},{"key":"1192_CR35","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1128\/JCM.00265-08","volume":"46","author":"A Yusof","year":"2008","unstructured":"Yusof A, Engelhardt A, Karlsson A, Bylund L, Vidh P, Mills K et al (2008) Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA. J Clin Microbiol 46:3042\u20133047. https:\/\/doi.org\/10.1128\/JCM.00265-08","journal-title":"J Clin Microbiol"},{"key":"1192_CR36","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/AAC.50.2.428-438.2006","volume":"50","author":"L Cui","year":"2006","unstructured":"Cui L, Iwamoto A, Lian JQ, Neoh HM, Maruyama T, Horikawa Y, Hiramatsu K (2006) Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50:428\u2013438. https:\/\/doi.org\/10.1128\/AAC.50.2.428-438.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"1192_CR37","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","volume":"50","author":"L Cui","year":"2006","unstructured":"Cui L, Tominaga E, Neoh HM, Hiramatsu K (2006) Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50:1079\u20131082. https:\/\/doi.org\/10.1128\/AAC.50.3.1079-1082.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"1192_CR38","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3389\/fmicb.2019.01882","volume":"10","author":"M Kuroda","year":"2019","unstructured":"Kuroda M, Sekizuka T, Matsui H, Ohsuga J, Ohshima T, Hanaki H (2019) IS256-mediated overexpression of the WalKR two-component system regulon contributes to reduced vancomycin susceptibility in a Staphylococcus aureus Clinical Isolate. Front Microbiol 10:1882. https:\/\/doi.org\/10.3389\/fmicb.2019.01882","journal-title":"Front Microbiol"},{"key":"1192_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.meegid.2016.05.001","volume":"43","author":"S Di Gregorio","year":"2016","unstructured":"Di Gregorio S, Fernandez S, Perazzi B, Bello N, Famiglietti A, Mollerach M (2016) Increase in IS256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants. Infect Genet Evol 43:197\u2013202. https:\/\/doi.org\/10.1016\/j.meegid.2016.05.001","journal-title":"Infect Genet Evol"},{"key":"1192_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/jac\/45.4.421","volume":"45","author":"H Komatsuzawa","year":"2000","unstructured":"Komatsuzawa H, Ohta K, Sugai M, Fujiwara T, Glanzmann P, Berger-B\u00e4chiB SH (2000) Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus. J Antimicrob Chemother 45:421\u2013431. https:\/\/doi.org\/10.1093\/jac\/45.4.421","journal-title":"J Antimicrob Chemother"},{"key":"1192_CR41","doi-asserted-by":"publisher","first-page":"16107","DOI":"10.1038\/s41598-020-73108-x","volume":"10","author":"K Thitiananpakorn","year":"2020","unstructured":"Thitiananpakorn K, Aiba Y, Tan XE, Watanabe S, Kiga K, Sato\u2019o Y et al (2020) Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA). Sci Rep 10:16107. https:\/\/doi.org\/10.1038\/s41598-020-73108-x","journal-title":"Sci Rep"},{"key":"1192_CR42","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/infdis\/jis252","volume":"205","author":"DR Cameron","year":"2012","unstructured":"Cameron DR, Ward DV, Kostoulias X, Howden BP, Moellering RC Jr, Eliopoulos GM, Peleg AY (2012) Serine\/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. J Infect Dis 205:1677\u20131687. https:\/\/doi.org\/10.1093\/infdis\/jis252","journal-title":"J Infect Dis"},{"key":"1192_CR43","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3389\/fmicb.2016.01601","volume":"7","author":"Q Hu","year":"2016","unstructured":"Hu Q, Peng H, Rao X (2016) Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus. Front Microbiol 7:1601. https:\/\/doi.org\/10.3389\/fmicb.2016.01601","journal-title":"Front Microbiol"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01192-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-023-01192-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01192-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T06:10:21Z","timestamp":1709878221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-023-01192-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1192"],"URL":"https:\/\/doi.org\/10.1007\/s42770-023-01192-y","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"type":"print","value":"1517-8382"},{"type":"electronic","value":"1678-4405"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"3 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}